Trials / Enrolling By Invitation
Enrolling By InvitationNCT07220330
An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Qbtech AB · Industry
- Sex
- All
- Age
- 6 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.
Detailed description
This study aims to evaluate the performance of QbMobile in children, adolescents, and adults from the normative population, those referred for an initial ADHD assessment, and individuals with an ADHD diagnosis who are not currently receiving ADHD treatment. Participants will complete the 10-minute QbMobile test on their personal device during a scheduled clinical visit. They will then repeat the test remotely the following day at the same time as the previous test +/-3 hours. For participants referred for an ADHD assessment or a has an ADHD diagnosis, QbMobile must be completed prior to initiating any ADHD treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | QbMobile | QbMobile is a software application that can be installed on a smartphone device used to measure activity, attention, impulsivity, and movement patterns in participants over a two-day period. |
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2025-10-23
- Last updated
- 2025-12-31
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07220330. Inclusion in this directory is not an endorsement.